Related Experiment Video
Updated: Aug 28, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality
Sana Rashid1,2, Giselle Alexandra Suero-Abreu3,4, Maciej Tysarowski3,5
1Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA rashidsana50@gmail.com.
Insights
Implementing an online tool and physician education improved statin prescribing for atherosclerotic cardiovascular disease (ASCVD) prevention. This quality improvement project increased statin prescriptions and cholesterol monitoring, enhancing guideline adherence.
Area of Science:
- Cardiology
- Public Health
- Health Informatics
Background:
- Statins are crucial for atherosclerotic cardiovascular disease (ASCVD) primary and secondary prevention.
- Previous audits revealed suboptimal statin prescribing and inadequate cholesterol monitoring.
- Adherence to cholesterol guidelines remains a challenge in clinical practice.
Purpose of the Study:
- To enhance adherence to cholesterol guidelines through a quality improvement initiative.
- To increase appropriate statin prescription rates and improve treatment monitoring.
- To evaluate the impact of multi-faceted interventions on ASCVD prevention.
Main Methods:
- A 4-month quality improvement project was implemented.
- Interventions included an interactive online tool, physician education, guideline summaries, and EHR reminders.
- Patient encounters were analyzed pre- and post-intervention to assess outcomes.
Main Results:
- Statin prescription rates improved significantly post-intervention (90.5% vs 82.3%, p=0.006).
- Documentation of 10-year ASCVD risk scores increased (72.3% vs 57.8%, p=0.039) for indicated patients.
- Follow-up cholesterol monitoring increased substantially (64.1% vs 33.3%, p<0.001).
Conclusions:
- Multi-faceted interventions, centered on an online tool, effectively improved statin prescribing and monitoring.
- The project demonstrated successful enhancement of ASCVD prevention guideline adherence.
- Quality improvement initiatives are vital for optimizing cardiovascular disease management.
Abstract:
Statins are indicated for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD). Our previous study of 1042 consecutive patient encounters at our large urban academic institution found that one in five patients were not prescribed an appropriate statin therapy. Only one-third of patients had follow-up cholesterol levels ordered to monitor treatment efficacy. In order to improve adherence to cholesterol guidelines at our institution, a quality improvement project was undertaken. We implemented interventions over a 4-month period to improve statin prescription rates: (a) development of an online interactive tool, (b) physician education on updated cholesterol guidelines and utilisation of the tool, (c) display of guideline summary in the workspace and (d) a documentation reminder in the electronic health record. We randomly selected encounter dates, from which 622 consecutive patient encounters were analysed. The primary outcome measures were prescription rates of statins, documentation of a 10-year ASCVD risk score and follow-up cholesterol levels ordered to monitor treatment efficacy. Out of the 622 patient encounters, 232 met statin indication. In this post-intervention group, statin prescription rates improved when compared with the pre-intervention group (90.5% vs 82.3%, p=0.006). Among patients who met statin indication solely via a 10-year ASCVD risk score ≥7.5%, there was an increase in documentation of the calculated 10-year ASCVD risk score (72.3% vs 57.8%; p=0.039) and in statin prescription rate (90.8% vs 67.6%; p<0.001). In addition, there was an increase in follow-up cholesterol levels ordered in all patients included in our study who met statin indication (64.1% vs 33.3%; p<0.001). Our quality improvement project showed higher rates of statin prescription, 10-year ASCVD risk score documentation and treatment monitoring after multiple interventions, centred on an easily accessible online interactive tool.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management

